Biotech News
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
investors.blackdiamondtherapeutics.com2026-05-06 15:10 EST
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced that its Chief Executive Officer, Mark Velleca,